메뉴 건너뛰기
Journal of Clinical Gastroenterology
Volumn 42, Issue 5, 2008, Pages 551-552
Hemolytic-uremic syndrome associated with gemcitabine treatment for metastatic pancreatic cancer
Author keywords

[No Author keywords available]
Indexed keywords

FRESH FROZEN PLASMA; GEMCITABINE; IRINOTECAN;
EID: 42449105802     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e31802da22e     Document Type: Letter
Times cited : (8)
References (7)
  • 1
    • 8244254377 scopus 로고    scopus 로고
    • Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial
    • Burris HA, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol. 1997;15:2403-2413.
    • (1997) J Clin Oncol , vol.15 , pp. 2403-2413
    • Burris, H.A.1    Moore, M.J.2    Andersen, J.3
  • 2
    • 2642566772 scopus 로고    scopus 로고
    • Gemcitabine-associated thrombotic microangiopathy
    • Humphreys BD, Sharman JP, Henderson JM, et al. Gemcitabine-associated thrombotic microangiopathy. Cancer. 2004;100:2664-2670.
    • (2004) Cancer , vol.100 , pp. 2664-2670
    • Humphreys, B.D.1    Sharman, J.P.2    Henderson, J.M.3
  • 3
    • 27244450452 scopus 로고    scopus 로고
    • Hemolytic-uremic syndrome associated with gemcitabine: A case report and review of the literature
    • Saif MW, McGee PJ. Hemolytic-uremic syndrome associated with gemcitabine: a case report and review of the literature. JOP. 2005;6:369-374.
    • (2005) JOP , vol.6 , pp. 369-374
    • Saif, M.W.1    McGee, P.J.2
  • 4
    • 0033134916 scopus 로고    scopus 로고
    • A review of hemolytic uremic syndrome in patients treated with gemcitabine therapy
    • Fung MC, Storniolo AM, Nguyen B, et al. A review of hemolytic uremic syndrome in patients treated with gemcitabine therapy. Cancer. 1999;85:2023-2031.
    • (1999) Cancer , vol.85 , pp. 2023-2031
    • Fung, M.C.1    Storniolo, A.M.2    Nguyen, B.3
  • 5
    • 6944226234 scopus 로고    scopus 로고
    • Gemcitabine and haemolytic-uraemic syndrome
    • Ruiz I, Del Valle J, Gomez A. Gemcitabine and haemolytic-uraemic syndrome. Ann Oncol. 2004;15:1575-1576.
    • (2004) Ann Oncol , vol.15 , pp. 1575-1576
    • Ruiz, I.1    Del Valle, J.2    Gomez, A.3
  • 6
    • 4644327989 scopus 로고    scopus 로고
    • Irinotecan plus gemcitabine results in no survival advantage compared to gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate
    • Rocha Lima CM, Green MR, Rotche R, et al. Irinotecan plus gemcitabine results in no survival advantage compared to gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate. J Clin Oncol. 2004;22:3776-3783.
    • (2004) J Clin Oncol , vol.22 , pp. 3776-3783
    • Rocha Lima, C.M.1    Green, M.R.2    Rotche, R.3
  • 7
    • 33846341510 scopus 로고    scopus 로고
    • A phase II study of weekly irinotecan as first-line therapy for patients with metastatic pancreatic cancer
    • Ueno H, Okusaka T, Funakoshi A, et al. A phase II study of weekly irinotecan as first-line therapy for patients with metastatic pancreatic cancer. Cancer Chemother Pharmacol. 2007;59:447-454.
    • (2007) Cancer Chemother Pharmacol , vol.59 , pp. 447-454
    • Ueno, H.1    Okusaka, T.2    Funakoshi, A.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.